1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Marketing & Advertising

MacuHealth Asserts ‘Rigorous Process’ In Research Supporting Claims, But No Bill Of Health From NAD

SBLA Beauty Doesn’t Answer NAD Request For Eye Lift Claims Support

 
• By Malcolm Spicer

“MacuHealth believes challenged claims are thoroughly supported by the multitude of peer reviewed, published scientific studies” but NAD review on Vision Elements challenge finds firm’s research doesn’t support its claims.

• Source: Shutterstock

MacuHealth LP saw fit to stop using more than 60 ad claims for its vision health and other supplements a competitor challenged but doesn’t see eye-to-eye with an industry self-regulation group saying research the firm provided doesn’t support the smaller number of claims it continued using.

“MacuHealth believes that the challenged claims are thoroughly supported by the multitude of peer reviewed, published scientific studies” discussed...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

Get To Know: Healthy Aging Specialist Prime Fifty

 
• By David Ridley

Established by Max Gowland in 2013, Prime Fifty was founded to address the specific nutritional needs of the over 50s.

Haleon Adds High Strength Vitamin D To UK Centrum Multivitamin Line

 
• By David Ridley

Centrum Vitamin D Boost combines a wide range of daily vitamins with a 30-microgram dose of vitamin D, delivering six times more of the micronutrient than the firm’s Centrum Advance.

EU Green Claims Directive: Commission Says It ‘Has Not Withdrawn’ From Negotiations

 
• By David Ridley

What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.

OLLY’s Lovin’ Libido Claims Score Support With Studies Of Women Reporting ‘Generally Low’ Desire

 
• By Malcolm Spicer

NAD reports the populations of six of seven RCTs Olly referenced as evidence were key in substantiating claims for Lovin’ Libido ashwagandha supplement challenged by Bayer. Supplement industry, though, is challenging the FTC’s RCT standard for claims support.

More from Business

US Consumer Health Q2 Earnings Preview: Baggage Comes With Costs, Expectations

 
• By Malcolm Spicer

In addition to impact from tariffs and executive suite changes, recent baggage for firms in the space include Perrigo divesting its branded Dermacosmetics business and Church & Dwight acquiring Touchland hand sanitizer brand.

Expanded Distribution In US Helps Drive Up BioGaia Sales

 
• By Tom Gallen

Swedish probiotics player BioGaia is reaping the benefits of increased marketing investments and distribution in the US.

Change In P&G’s Helm Coming As Planning For Impact From Tariff Increases In Difficulty

 
• By Malcolm Spicer

Even as CEO Jon Moeller and lead board member Joe Jiminez as well as analysts state confidence the firm’s growth strategy will continue with the executive suite change, the impact of tariff policies could put a dent in its results.